CSIMarket
 
Veradigm Inc   (MDRX)
 
Price: $4.8000 $-0.10 -2.041%
Day's High: $4.900000095367432 Week Perf: 0.00
Day's Low: $ 4.71 30 Day Perf: 0.00
Volume (M): 64,300 52 Wk High: $ 6.00
Volume (M$): $ 0 52 Wk Avg: $4.74
Open: $4.75 52 Wk Low: $3.25



 Market Capitalization (Millions $) 519
 Shares Outstanding (Millions) 108
 Employees 8,900
 Revenues (TTM) (Millions $) 593
 Net Income (TTM) (Millions $) -443
 Cash Flow (TTM) (Millions $) -409
 Capital Exp. (TTM) (Millions $) 0

Business Description


Allscripts Healthcare Solutions, Inc. (“Allscripts”) delivers information technology (“IT”) solutions and services to help healthcare organizations achieve optimal clinical, financial and operational results. Our solutions and services are sold to:

Physicians

Retail pharmacies

Hospitals

Pharmacy benefit managers

Governments

Insurance companies

Health systems

Employer wellness clinics

Health plans

Post-acute organizations

Life-sciences companies

Consumers

Retail clinics

Lab companies

Allscripts also completed a transaction pursuant to which Allscripts exchanged its entire holdings of the NantHealth common stock for NantHealth’s provider and patient engagement solutions business, including the FusionFX solution and components of NantOS software connectivity solutions. In addition, NantHealth amended its mutual license and reseller agreement with us to, among other things, commit to deliver a minimum dollar amount of software and related services from Allscripts over a 10-year period.

Our portfolio, which we believe offers some of the most comprehensive solutions in our industry today, is designed to help clients advance the quality and efficiency of healthcare by providing electronic health records (“EHR”), financial management, population health management and precision medicine/consumer solutions. Built on an open integrated platform, Allscripts solutions enable users to exchange data, streamline workflows and leverage functionality from other software vendors. The Allscripts Developer Program focuses on nurturing partnerships with other developers to help clients optimize the value of their Allscripts investment.

During 2017, we completed the acquisition of McKesson’s hospital and health system business known as Enterprise Information Solutions (“EIS”) (the “EIS Business”). It expands our ability to meet the strategic needs of a broader range of hospitals and health systems, ranging from critical access and community hospitals to the largest, most complex integrated delivery networks. We expect that our combined customer base will mutually benefit from the increased breadth of the Allscripts portfolio. For example, clients of the EIS Business will benefit from our numerous solutions that are designed to help them stay ahead in the increasingly competitive environment in which they operate: precision medicine, cross community care coordination, consumer solutions and financial analytics.

We derive our revenues primarily from sales of our proprietary software (either as a direct license sale or under a subscription delivery model), which also serves as the basis for our recurring service contracts for software support and maintenance and certain transaction-related services. In addition, we provide various other client services, including installation, and managed services such as outsourcing, private cloud hosting and revenue cycle management.



   Company Address: 222 Merchandise Mart Plaza Chicago 60654 IL
   Company Phone Number: 334-8534   Stock Exchange / Ticker: MDRX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AZPN   -0.25%    
KD        0.77% 
TBRG        0.11% 
BSY   -1.71%    
CVS        5.06% 
IBM   -1.19%    
• View Complete Report
   



Business Update

Veradigm Faces Delay in Financial Restatement Process as Competitor Allscripts Reports Revenue Decrease

Published Tue, Feb 27 2024 12:00 PM UTC

Veradigm Inc. (NASDAQ: MDRX), a prominent provider of healthcare data and technology solutions, recently announced a delay in filing its annual and quarterly reports. While the company strives to address its financial restatement process, its competitor, Allscripts Healthcare Solutions Inc, reported a significant decrease in revenue during the third quarter of 2022, in contr...

Product Service News

Veradigm Bolsters Healthcare with Enhanced Solutions for Patient Care, Cardiovascular Health, and Practice Management.

Published Thu, Feb 22 2024 1:01 PM UTC

Veradigm Innovates Healthcare Technology Solutions to Improve Patient Care, Cardiovascular Health, and Independent Practice Financial ManagementVeradigm, a prominent player in the healthcare data and technology solutions industry, has announced the launch of several new initiatives aimed at addressing critical gaps in patient care, promoting cardiovascular health, and enhanc...

Product Service News

Evolving Cardiovascular Health: Veradigm and American College of Cardiology's TRANSFORM VAX Initiative Puts Influenza Vaccination in the Spotlight

Published Tue, Feb 13 2024 1:01 PM UTC

Combating Cardiovascular Risks: Veradigm and American College of Cardiology Join Forces to Promote Influenza Vaccination EducationIn a groundbreaking move towards enhancing cardiovascular health, Veradigm Inc. and the American College of Cardiology (ACC) have teamed up to launch an innovative initiative called TRANSFORM VAX. This collaborative effort aims to foster awareness...

Announcement

Veradigm Inc. Faces Class Action Lawsuit: Shining Light on Alleged Accounting Fraud

Published Sat, Jan 20 2024 6:32 PM UTC

Veradigm Inc. (NASDAQ: MDRX), a prominent player in the healthcare solutions industry, is currently facing a class action lawsuit that alleges accounting fraud. This article explores the key details surrounding the lawsuit and provides an analysis of its potential impact on Veradigm and its investors. Background: Hagens Berman, a respected law firm, has encouraged Veradigm i...

Business Update

Veradigm's Dynamic Leadership Transforms Healthcare Landscape Amidst Industry Challenges

Published Wed, Jan 10 2024 1:01 PM UTC

Veradigm Inc., a renowned provider of healthcare data and technology solutions, recently unveiled its reinvigorated leadership team. Dr. Shih-Yin Ho, serving as the Interim CEO, and Lee Westerfield, as the Interim CFO, presented Veradigm s vision, business strategies, and innovation plans at the J.P. Morgan Healthcare Conference. Additionally, they provided an updated fiscal...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.88
Price to Sales (Expected) -
Price to Book 0.65
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.7
Working Capital Ratio 1.29
Leverage Ratio (MRQ) 0.68
Total Debt to Equity 0.28
Interest Coverage (TTM) 7.33
Debt Coverage (TTM) 0.32

Per Share Current
Earnings (TTM) -2.7 $
Revenues (TTM) 5.48 $
Cash Flow (TTM) -
Cash 2.72 $
Book Value 7.43 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 66,642
Net Income per Employee (TTM) -49,764
Receivable Turnover Ratio (TTM) 5.23
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.45

Profitability Ratios Current
Gross Margin (MRQ) 44.27 %
Operating Margin (MRQ) -148.49 %
Net Margin (MRQ) -178.11 %
Net Cash Flow Margin (MRQ) -274.68 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.